SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-18-004457
Filing Date
2018-09-11
Accepted
2018-09-11 16:01:17
Documents
76
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ipix_10k.htm 10-K 944873
2 CONSENT ipix_ex231.htm EX-23.1 1475
3 CERTIFICATION ipix_ex311.htm EX-31.1 8050
4 CERTIFICATION ipix_ex312.htm EX-31.2 8165
5 CERTIFICATION ipix_ex321.htm EX-32.1 3000
6 CERTIFICATION ipix_ex322.htm EX-32.2 3056
  Complete submission text file 0001477932-18-004457.txt   5102577

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ipix-20180630.xml EX-101.INS 944438
8 XBRL TAXONOMY EXTENSION SCHEMA ipix-20180630.xsd EX-101.SCH 78603
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20180630_cal.xml EX-101.CAL 49607
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20180630_def.xml EX-101.DEF 248788
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20180630_lab.xml EX-101.LAB 361919
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20180630_pre.xml EX-101.PRE 339651
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-37357 | Film No.: 181064919
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1